Welcome to our dedicated page for Cemtrex SEC filings (Ticker: CETX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trying to compare camera software margins with rigging backlogs inside the same report can feel impossible. Cemtrex’s disclosures jump from firmware development costs to crane liability reserves in a single section, making even seasoned analysts scroll endlessly. If you have ever Googled "Cemtrex SEC filings explained simply" or wondered why a 300-page 10-K buries segment revenue, you are not alone.
Stock Titan solves that problem. Our AI reads every Cemtrex annual report 10-K simplified, every Cemtrex quarterly earnings report 10-Q filing, and each Cemtrex 8-K material events explained alert the moment EDGAR releases them. It then surfaces what matters: which contracts moved the Security segment, how warranty accruals affect Industrial Services, and whether goodwill impairments are looming. Need real-time insight? Get instant pings for Cemtrex Form 4 insider transactions real-time so you never miss executive stock moves. Our dashboards translate dense accounting language into plain English—perfect for understanding Cemtrex SEC documents with AI in minutes, not hours.
Whether you are tracking a facility relocation contract or monitoring camera-unit sales, you will find exactly what you need: Cemtrex insider trading Form 4 transactions, Cemtrex proxy statement executive compensation details, and full Cemtrex earnings report filing analysis—all in one place. Stop parsing PDFs line by line; let our AI-powered summaries, real-time filing updates, and expert context show how each disclosure shapes Cemtrex’s future.
Cemtrex, Inc. entered a material definitive agreement, issuing a promissory note to Streeterville Capital, LLC with an original principal of $7,025,000. After $25,000 in original issuance fees, the company received $7,000,000 in cash.
Interest accrues at the daily SOFR rate from November 7, 2025 through December 31, 2025, then at 8% per annum beginning January 1, 2026. If the note remains outstanding on January 1, 2026, a one-time additional interest fee of $1,050,000 will be added to the balance. The note matures eighteen months from issuance, with redemptions starting six months after issuance. Cemtrex states it intends to use the cash proceeds to complete potential acquisitions.
CEMTREX Inc. is the subject of a jointly filed Schedule 13G/A by three Altium-related reporting persons that discloses no reportable stake in the company’s common stock. The filing names Altium Healthcare Long Short Onshore Fund LP, Altium Capital Management LLC and Altium Healthcare Long Short GP LLC and states the Fund as the record and direct beneficial owner of the securities covered by the statement while simultaneously reporting an aggregate beneficial ownership of 0 shares (0% of the class). The filers note they may be deemed members of a group for regulatory purposes but expressly state the filing is not an admission of beneficial ownership or of acting to acquire or influence control. The statement also includes a certification that the securities were not acquired to influence control.
This Schedule 13G/A discloses that Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC (the Reporting Persons) are each deemed to beneficially own 336,801 shares of Cemtrex Inc. common stock, representing approximately 9.99% of the company’s outstanding common stock as presented in the filing. The shares reported are issuable upon exercise of a warrant held by Intracoastal (Intracoastal Warrant 1).
Each Reporting Person has shared voting and shared dispositive power over 336,801 shares and no sole voting or dispositive power. The filing explains that blocker provisions in Intracoastal Warrant 1 and Intracoastal Warrant 2 prevent exercise to the extent doing so would increase ownership above 9.99% and 4.99%, respectively, thereby excluding 1,671,598 and 142,778 warrant shares from current beneficial ownership calculations. Without those blocker provisions, the Reporting Persons may be deemed to beneficially own 2,151,177 shares.
FAQ
What is the current stock price of Cemtrex (CETX)?
What is the market cap of Cemtrex (CETX)?
